Paige Marquez

4.8k citations

58 papers · 1.8k indexed · 2 hit papers · h-index 23

Infectious Diseases top 1%
Health top 1%
Surgery top 10%
Epidemiology top 10%
Cardiology and Cardiovascular Medicine top 10%

Co-authors: John R. Su Tom T. Shimabukuro Julianne Gee Tanya R. Myers David K. Shay Anne M. Hause Bicheng Zhang James Baggs
Topics: Vaccine Coverage and Hesitancy (27 papers)SARS-CoV-2 and COVID-19 Research (26 papers)Heparin-Induced Thrombocytopenia and Thrombosis (12 papers)
Cited by: Health Infectious Diseases Obstetrics and Gynecology
Journals: PEDIATRICS The Journal of Infectious Diseases The Lancet Infectious Diseases
Partner nations: United States Uganda United Kingdom

In The Last Decade

Paige Marquez

57 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

2021 275 citations Julianne Gee, Paige Marquez et al. MMWR Morbidity and Mortality Weekly Report profile →
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

2022 116 citations Julianne Gee, Paige Marquez et al. profile →

Peers

Countries citing papers authored by Paige Marquez

Since Specialization

Citations

This map shows the geographic impact of Paige Marquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paige Marquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paige Marquez more than expected).

Fields of papers citing papers by Paige Marquez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paige Marquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paige Marquez. The network helps show where Paige Marquez may publish in the future.

Co-authorship network of co-authors of Paige Marquez

This figure shows the co-authorship network connecting the top 25 collaborators of Paige Marquez. A scholar is included among the top collaborators of Paige Marquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paige Marquez. Paige Marquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants 2025 ·JAMA Pediatrics ·Rachel G. Greenberg,Wes Rountree,Mary Allen Staat,Elizabeth P. Schlaudecker,Brenda B. Poindexter,Andrea Trembath,Matthew M. Laughon,Marek S. Poniewierski,Rachel L. Spreng,Karen R. Broder,A. Patricia Wodi,Oidda Museru,(unknown),Paige Marquez,(unknown),Samia Aleem,(unknown),Emmanuel B. Walter	0
2	Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalink 2024 ·American Journal of Otolaryngology ·W. Katherine Yih,Jonathan Duffy,John R. Su,(unknown),Bruce Fireman,Laura P. Hurley,Judith C. Maro,Paige Marquez,Pedro L. Moro,Narayan Nair,Jennifer C. Nelson,Ning Smith,Maria E. Sundaram,(unknown),Eric Weintraub,Stanley Xu,Tom T. Shimabukuro	1
3	Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System – United States, September 1, 2022 – March 31, 2023 2024 ·Vaccine ·Pedro L. Moro,(unknown),Nimita Fifadara,(unknown),Bicheng Zhang,Penelope Strid,Paige Marquez	4
4	Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS) 2024 ·Drug Safety ·(unknown),Paige Marquez,(unknown),Phillip G. Blanc,Kerry J. Welsh,Narayan Nair,Mônica Taminato,Pedro L. Moro	2
5	Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021–February 2022 2023 ·Vaccine ·Emily Jane Woo,Julianne Gee,Paige Marquez,James Baggs,Winston E. Abara,Michael M. McNeil,Rositsa B. Dimova,John R. Su	8
6	Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·Anne M. Hause,Paige Marquez,Bicheng Zhang,John R. Su,Tanya R. Myers,Julianne Gee,S. Panchanathan,Deborah Thompson,Tom T. Shimabukuro,David K. Shay	23
7	Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023 2023 ·MMWR Morbidity and Mortality Weekly Report ·(unknown),Pedro L. Moro,John R. Su,Paige Marquez,Narayan Nair,(unknown),(unknown),Tom T. Shimabukuro	2
8	Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States 2023 ·JAMA Network Open ·Winston E. Abara,Julianne Gee,Paige Marquez,(unknown),Tanya R. Myers,(unknown),Jane Baumblatt,Emily Jane Woo,Deborah Thompson,Narayan Nair,John R. Su,Tom T. Shimabukuro,David K. Shay	41
9	Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS) 2023 ·Vaccine ·A. Patricia Wodi,Paige Marquez,Adamma Mba‐Jonas,(unknown),(unknown),Pedro L. Moro	2
10	Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021–June 30, 2022 2023 ·Vaccine ·Pedro L. Moro,Bicheng Zhang,(unknown),Margaret Harris,(unknown),Gina Woody,Paige Marquez,Michael M. McNeil,John R. Su	18
11	Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021 2022 ·Vaccine ·Pedro L. Moro,Christine K. Olson,Elizabeth Clark,Paige Marquez,Penelope Strid,Sascha Ellington,Bicheng Zhang,Adamma Mba‐Jonas,Meghna Alimchandani,Janet D. Cragan,Cynthia A. Moore	23
12	Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults 2022 ·Vaccine ·Lindsay K. Tompkins,James Baggs,Tanya R. Myers,Julianne Gee,Paige Marquez,(unknown),D. J. Peake,(unknown),Anne M. Hause,Penelope Strid,Winston E. Abara,(unknown),Tom T. Shimabukuro,David K. Shay	2
13	Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015–2018 2021 ·Vaccine ·Silvia Pérez-Vilar,Graça M. Dores,Paige Marquez,Carmen S. Ng,Maria Cano,(unknown),Lucia Lee,John R. Su,Jonathan Duffy	6
14	Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system 2021 ·Vaccine ·Johanna Chapin-Bardales,Tanya R. Myers,Julianne Gee,David K. Shay,Paige Marquez,James Baggs,Bicheng Zhang,Charles Licata,Tom T. Shimabukuro	10
15	Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018 2021 ·Vaccine ·John R. Su,Michael M. McNeil,Kerry J. Welsh,Paige Marquez,Carmen S. Ng,Ming Yan,Maria Cano	113
16	Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 – 2019 2020 ·Vaccine ·Pedro L. Moro,Emily Jane Woo,Paige Marquez,Maria Cano	13
17	Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010–December 2018 2019 ·Vaccine ·Penina Haber,Pedro L. Moro,Carmen S. Ng,Graça M. Dores,Silvia Pérez-Vilar,Paige Marquez,Maria Cano	4
18	Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 2019 ·Vaccine ·John R. Su,Penina Haber,Carmen S. Ng,Paige Marquez,Graça M. Dores,Silvia Pérez-Vilar,Maria Cano	32
19	Adverse events following adenovirus type 4 and type 7 vaccine, live, oral in the Vaccine Adverse Event Reporting System (VAERS), United States, October 2011–July 2018 2019 ·Vaccine ·Michael M. McNeil,Iwona Paradowska‐Stankiewicz,Elaine R. Miller,Paige Marquez,(unknown),Limone Collins,Maria Cano	19
20	Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007–2017 2019 ·Vaccine ·Pedro L. Moro,Jorge E. Araña,Paige Marquez,Carmen S. Ng,(unknown),Beth F. Hibbs,Maria Cano	9

About Paige Marquez

Paige Marquez is a scholar working on Health, Toxicology and Infectious Diseases, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (27 papers), SARS-CoV-2 and COVID-19 Research (26 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (12 papers). The work is most often cited by research in Health (630 citations), Infectious Diseases (1.1k citations) and Obstetrics and Gynecology (184 citations). Paige Marquez has collaborated with scholars based in United States, Uganda and United Kingdom. Frequent co-authors include John R. Su, Tom T. Shimabukuro, Julianne Gee, Tanya R. Myers, David K. Shay, Anne M. Hause, Bicheng Zhang, James Baggs, Maria Cano and Deborah Thompson. Their work appears in journals such as PEDIATRICS, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact